SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001615774-16-005443
Filing Date
2016-05-16
Accepted
2016-05-16 15:07:58
Documents
11

Document Format Files

Seq Description Document Type Size
1 10-12G/A s103198_10-12ga.htm 10-12G/A 995555
2 EXHIBIT 10-5 s103198_ex10-5.htm EX-10.5 315085
3 EXHIBIT 10-11 s103198_ex10-11.htm EX-10.11 674712
4 EXHIBIT 10-13 s103198_ex10-13.htm EX-10.13 78629
5 EXHIBIT 10-14 s103198_ex10-14.htm EX-10.14 68754
6 EXHIBIT 10-15 s103198_ex10-15.htm EX-10.15 15989
7 EXHIBIT 10-16 s103198_ex10-16.htm EX-10.16 10454
8 GRAPHIC tex10-5sig.jpg GRAPHIC 10694
9 GRAPHIC tex10-11pg64a.jpg GRAPHIC 6119
10 GRAPHIC tex10-11pg64b.jpg GRAPHIC 4285
11 GRAPHIC tex10-13_logo.jpg GRAPHIC 5170
  Complete submission text file 0001615774-16-005443.txt   2196906
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-12G/A | Act: 34 | File No.: 000-55506 | Film No.: 161653059
SIC: 2834 Pharmaceutical Preparations